CADFEM
VC Fund
Farmington Hills, United States
CADFEM is a VC fund in Farmington Hills focused on Software and Medical Device. CADFEM provides engineering analysis software sales, consultancy, training and technical services to a variety of global and UK customers.These products provide engineers with broad, high end analysis functionality for the development of leading edge products and state of the art manufacturing processes. Cumulatively our group of 18 skilled andmotivated staff have more than 100 years experience in providing and supporting simulation led engineering solutions. Our expertise is spread across a wide range of engineering sectors: medical devices, renewable energy, aerospace, automotive, civil engineering, mechanical engineering, power engineering amongst others. Working with the ANSYS suite of simulation products we are expert in its customisation for particular engineering applications. In addition we have recently developed cloud based hardware solutions for our client base which enables flexible, economic and on demand access to high end computing resources over the web. We have expertise in linear and nonlinear, static and dynamic, implicit and explicit, stress analyses, steady state and transient heat transfer analysis, computational fluid dynamics analysis, fluid-structure analysis.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries CADFEM invests in
Stages CADFEM invests in
Countries CADFEM invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2.2M–$3.5M
- Pre-Seed
- $235k–$308k
Investment Focus
Industry
- Software 2 (29%)
- Medical Device 2 (29%)
- CAD 1 (14%)
- Medical 1 (14%)
- Wellness 1 (14%)
Stage
- Seed 3 (43%)
- Pre-Seed 1 (14%)
- Convertible Note 1 (14%)
- Venture - Series Unknown 1 (14%)
Country
- Switzerland 5 (71%)
- Germany 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adrian Dunne
Simulation Engineer
|
Simulation Engineer | Total investments: 0 | Find email | |
Bob Moore
IT Manager
|
IT Manager | Total investments: 0 | Find email | |
Derek Sweeney
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Citus improves skin monitoring by mechanical characterization and provides a range of services. | $412.1K / Convertible Note / Oct 06, 2023 | ||
| Side Effects is an automatic digital 3D from CAD data and an easy-to-use 3D editing system. It creates 3D-based work instructions, manuals, technical documentation, assembly instructions, and spare parts catalogues. | $1M / Venture - Series Unknown / Jul 22, 2022 | ||
| Internet of Humans: in which our bodies drive, actively and passively, our experiences with connected devices. We have a holistic understanding of all aspects of the value chain from brain activity to product integration. This value chain includes: (1) innovative biosensor development, (2) custom hardware design; (3) data collection and analysis;and (4) product integration.IDUN Technologies integrates neuroscience into every-day product designs, enabling connected devices to understand the emotional needs of people, providing for happier and more fulfilling product experiences. IDUN achieves this by delivering the full neurofeedback value chain from electrode manufacturing to product design integration. This allows the brain waves of an individual to be comfortably characterized through-out the day to understand their unique emotional needs. Through the IDUN API, actional inputs are sent to connected devices, providing more interactive and fulfilling product experiences. Our goal is to fuse emotion intelligence with connected devices, enabling cohesion and understanding between humans and the connected world. Electroencephalography (EEG) imaging of the brain allows us to characterize the way in which our brain processes information. From EEG signals we extract features related to the emotional and cognitive loads of people. While EEG recording has been used in controlled laboratory environments for decades, it has not been integrated into consumer devices that seamlessly integrate with daily life. We believe that daily measurements of the brain will unlock insights that are not possible with only laboratory measurements. Each brain is unique, with its own algorithm that we are focused on decoding. We translate EEG biomarkers from research findings into our product design and build upon research by developing tests that empirically characterize the brain activity resulting from specific environmental inputs. The goal is to not simply provide the end user with a recording of their brain as a complex data stream, but to give them actionable insights, or passively change their digital experience to better suit their brain state. | $2.2M / Seed / Sep 02, 2021 | ||
| aSR offers an innovative software platform for virtual vehicle development enabling the management of simulation data, the setup of the virtual prototype and to perform virtual test drives. The goal is to shorten the development process, reduce the number of real-world tests and to experience simulation. | $308K / Pre-Seed / Jul 01, 2021 | ||
| FenX is a recyclable insulating product that turns mineral waste into usable resources to support a circular economy. Real estate developers, construction companies, and architects can now access non-flammable insulation materials for construction processes. the company's portfolio of recyclable insulation materials, which includes foamproducts and foam formulations made from readily available waste or natural materials with CO2 emissions. | $2.7M / Seed / May 10, 2021 | ||
| aSR offers an innovative software platform for virtual vehicle development enabling the management of simulation data, the setup of the virtual prototype and to perform virtual test drives. The goal is to shorten the development process, reduce the number of real-world tests and to experience simulation. | $235.3K / Pre-Seed / May 01, 2019 | ||
| Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management. | $3.5M / Seed / Feb 14, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does CADFEM invest in?
CADFEM invests primarily in Software, Medical Device and CAD startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is CADFEM's check size?
CADFEM typically joins rounds of $2.2M–$3.5M at Seed and $235k–$308k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CADFEM participates in.
How do I contact CADFEM?
Public channels for CADFEM include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CADFEM?
The team at CADFEM includes Adrian Dunne (Simulation Engineer), Bob Moore (IT Manager) and Derek Sweeney (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
